Apollon Formularies PLC, formerly AfriAg Global PLC, is a United Kingdom-based medical cannabis pharmaceutical company. The Company is engaged in specializing in cutting-edge research and treatment of patients with cancer and chronic pain. The Company has hybrid medical cannabis pharmaceutical strains, technology, formulations and treatment products. Its products with trademarks include APOLLON-FULL EXTRACT CANNABIS OIL (FECO) Vape, APOLLON FECO Oral Tincture-30ml Bottle and APOLLON FECO Prescribed Capsules. It also includes Apollon NAUSEA Apollon PAIN, Apollon SLEEP, Apollon ANTI-INFLAMMATORY, Apollon SEIZURES, Apollon APPETITE and Apollon CANCER. It offers services, including Cultivation, Processing and Extraction, International Cancer Institute, Retail Product Sales, Apollon Negril Facility, Research and Development, and Bespoke Treatments and Products. The Company’s subsidiary is Apollon Formularies Jamaica Ltd.